Basics Avidity Biosciences, Inc. IPO Date: June 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $6.48B Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 3.28% Avg Daily Range (30 D): $1.27 | 3.10% Avg Daily Range (90 D): $1.00 | 2.86% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): 2.76M Avg Daily Volume (90 D): 1.85M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 81 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 2,624 Avg Inst. Trade: $2.9M Avg Inst. Trade (30 D): $4.6M Avg Inst. Trade (90 D): $3.68M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.88M Avg Closing Trade (30 D): $10.96M Avg Closing Trade (90 D): $7.36M Avg Closing Volume: 151.91K     News Jul 1, 2024 @ 5:38 PM Top Performing Industry ETFs In June: Software Lea... Source: Piero Cingari Jun 13, 2024 @ 2:39 PM Avidity (RNA) Up 33% on Rare Muscle Disease Study ... Source: Zacks Equity Research Jun 10, 2024 @ 12:01 PM A Glimpse Into The Expert Outlook On Avidity Biosc... Source: Benzinga Insights May 29, 2024 @ 12:45 PM 2 Potentially High-Reward Growth Stocks to Buy Rig... Source: newsfeedback@fool.com (George Budwell) May 9, 2024 @ 9:15 PM Coherus BioSciences (CHRS) Reports Q1 Loss, Misses... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.21 $-.9 Diluted EPS $-1.21 $-.9 Revenue $ $ 3.85M $ 1.57M Gross Profit $ $ $ Net Income / Loss $ $ -157.32M $ -115.77M Operating Income / Loss $ $ -171.14M $ -131.52M Cost of Revenue $ $ $ Net Cash Flow $ $ -10.29M $ 34.34M PE Ratio